title: Tacrolimus-induced hemolytic uremic syndrome case presentation in a lung transplant recipient.
authors.affiliation: Pulmonary Institute, Rabin Medical Center, Belinson Campus, Petach Tikva, Israel.
authors.forename: D
authors.initials: D
authors.lastname: Shitrit
authors.forename: D
authors.initials: D
authors.lastname: Starobin
authors.forename: D
authors.initials: D
authors.lastname: Aravot
authors.forename: G
authors.initials: G
authors.lastname: Fink
authors.forename: G
authors.initials: G
authors.lastname: Izbicki
authors.forename: M
authors.initials: M
authors.lastname: Kramer
mesh_terms: D001794:Blood Pressure; D006463:Hemolytic-Uremic Syndrome / Q000139:chemically induced*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016040:Lung Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008875:Middle Aged; D011674:Pulse; D016559:Tacrolimus / Q000009:adverse effects*
chemical_list: D007166:Immunosuppressive Agents; D016559:Tacrolimus